Trulieve Cannabis Corp. to Hold Third Quarter 2023 Results Conference Call on November 9, 2023

2023-10-20
财报
TALLAHASSEE, Fla., Oct. 20, 2023  /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., will hold a conference call on Thursday, November 9, 2023 at 8:30 AM Eastern Time following the release of its third quarter 2023 financial results.
Chairman, Founder, and Chief Executive Officer Kim Rivers and Interim Chief Financial Officer Ryan Blust will participate on the call to review Trulieve's financial and operating results.
Interested parties can join the conference call by dialing in as directed below. Please dial in 15 minutes prior to the call and ask to join the Trulieve Cannabis Corp. call.
North American toll free: 1-888-317-6003          Passcode:      8045472
International: 1-412-317-6061                            Passcode:      8045472
A live audio webcast of the conference call will be available at:
https://app.webinar.net/RXq1eDnkyL2
An archived replay of the webcast will be available at:
https://investors.trulieve.com/events
About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.
Facebook: @Trulieve
Instagram: @Trulieve_
Twitter: @Trulieve
Investor Contact
Christine Hersey, Vice President of Investor Relations
+1 (424) 202-0210
[email protected]
Media Contact
Phil Buck, APR, Corporate Communications Manager
+1 (406) 370-6226
[email protected]
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。